Takahashi S - Search Results

1

Changes in Neutrophil-to-lymphocyte Ratio Predict Efficacy of Trabectedin for Soft-tissue Sarcoma.

Sato Y, Nakano K, Kawaguchi K, Fukuda N, Wang X, Urasaki T, Ohmoto A, Hayashi N, Yunokawa M, Ono M, Tomomatsu J, Hayakawa K, Funauchi Y, Tanizawa T, Ae K, Matsumoto S, Takahashi S. Sato Y, et al. Among authors: takahashi s. Cancer Diagn Progn. 2021 Jul 3;1(4):303-308. doi: 10.21873/cdp.10040. eCollection 2021 Sep-Oct. Cancer Diagn Progn. 2021. PMID: 35403143 Free PMC article.

2

Tumor size is a potential predictor of response to tyrosine kinase inhibitors in renal cell cancer.

Yuasa T, Urakami S, Yamamoto S, Yonese J, Nakano K, Kodaira M, Takahashi S, Hatake K, Inamura K, Ishikwa Y, Fukui I. Yuasa T, et al. Among authors: takahashi s. Urology. 2011 Apr;77(4):831-5. doi: 10.1016/j.urology.2010.12.008. Epub 2011 Feb 12. Urology. 2011. PMID: 21316083

3

Clinical efficacy and prognostic factors for overall survival in Japanese patients with metastatic renal cell cancer treated with sunitinib.

Yuasa T, Tsuchiya N, Urakami S, Horikawa Y, Narita S, Inoue T, Saito M, Yamamoto S, Yonese J, Fukui I, Nakano K, Takahashi S, Hatake K, Habuchi T. Yuasa T, et al. Among authors: takahashi s. BJU Int. 2012 May;109(9):1349-54. doi: 10.1111/j.1464-410X.2011.10534.x. Epub 2011 Aug 25. BJU Int. 2012. PMID: 21883864

4

High thymidine kinase activity is a strong predictive factor for poor prognosis in peripheral T-cell lymphoma treated with cyclophosphamide, adriamycin, vincristine and prednisone.

Suzuki K, Terui Y, Nakano K, Nara E, Nasu K, Ueda K, Nishimura N, Mishima Y, Sakajiri S, Yokoyama M, Takahashi S, Hatake K. Suzuki K, et al. Among authors: takahashi s. Leuk Lymphoma. 2012 May;53(5):849-54. doi: 10.3109/10428194.2011.635858. Leuk Lymphoma. 2012. PMID: 22035416

5

Prospective evaluation of incidence and severity of oral mucositis induced by conventional chemotherapy in solid tumors and malignant lymphomas.

Nishimura N, Nakano K, Ueda K, Kodaira M, Yamada S, Mishima Y, Yokoyama M, Terui Y, Takahashi S, Hatake K. Nishimura N, et al. Among authors: takahashi s. Support Care Cancer. 2012 Sep;20(9):2053-9. doi: 10.1007/s00520-011-1314-6. Epub 2011 Nov 25. Support Care Cancer. 2012. PMID: 22116139

6

Feasibility and efficacy of combined cisplatin and irinotecan chemotherapy for poorly differentiated neuroendocrine carcinomas.

Nakano K, Takahashi S, Yuasa T, Nishimura N, Mishima Y, Sakajiri S, Yokoyama M, Tsuyama N, Ishikawa Y, Hatake K. Nakano K, et al. Among authors: takahashi s. Jpn J Clin Oncol. 2012 Aug;42(8):697-703. doi: 10.1093/jjco/hys085. Epub 2012 Jun 13. Jpn J Clin Oncol. 2012. PMID: 22701038

7

Incidence of pneumothorax in advanced and/or metastatic soft tissue sarcoma patients during pazopanib treatment.

Nakano K, Inagaki L, Tomomatsu J, Motoi N, Gokita T, Ae K, Tanizawa T, Shimoji T, Matsumoto S, Takahashi S. Nakano K, et al. Among authors: takahashi s. Clin Oncol (R Coll Radiol). 2014 Jun;26(6):357. doi: 10.1016/j.clon.2014.02.010. Epub 2014 Mar 12. Clin Oncol (R Coll Radiol). 2014. PMID: 24630810 No abstract available.

8

Differences in the responses to pazopanib and the prognoses of soft tissue sarcomas by their histological eligibility for the PALETTE study.

Nakano K, Motoi N, Inagaki L, Tomomatsu J, Gokita T, Ae K, Tanizawa T, Shimoji T, Matsumoto S, Takahashi S. Nakano K, et al. Among authors: takahashi s. Jpn J Clin Oncol. 2015 May;45(5):449-55. doi: 10.1093/jjco/hyv022. Epub 2015 Feb 26. Jpn J Clin Oncol. 2015. PMID: 25724217

9

The CYVADIC regimen as a combination chemotherapy treatment option for advanced soft tissue sarcomas originating from the non-extremities.

Nakano K, Motoi N, Takahashi S. Nakano K, et al. Among authors: takahashi s. Intern Med. 2015;54(2):187-93. doi: 10.2169/internalmedicine.54.1703. Epub 2015 Jan 15. Intern Med. 2015. PMID: 25743010 Free article.

10

Predictive factors of head and neck squamous cell carcinoma patient tolerance to high-dose cisplatin in concurrent chemoradiotherapy.

Nakano K, Sato Y, Toshiyasu T, Sato Y, Inagaki L, Tomomatsu J, Sasaki T, Shimbashi W, Fukushima H, Yonekawa H, Mitani H, Kawabata K, Takahashi S. Nakano K, et al. Among authors: takahashi s. Mol Clin Oncol. 2016 Feb;4(2):303-309. doi: 10.3892/mco.2015.687. Epub 2015 Nov 25. Mol Clin Oncol. 2016. PMID: 26893880 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

11,129 results

Search Page